[Bilateral breast bacterial cellulite secondary to Streptococcus agalactiae septicemia]

Ann Dermatol Venereol. 2006 Feb;133(2):171-3. doi: 10.1016/s0151-9638(06)70872-9.
[Article in French]

Abstract

Background: We report a case of group B streptococcal septicemia of digestive origin with secondary bilateral breast dermal-hypodermal localization.

Case report: A 71 year-old woman with a past history of bilateral breast cancer treated by conservation therapy was hospitalized because of the sudden occurrence of two clearly delimited, inflammatory, dermal-hypodermal cutaneous plaques located on each breast, associated with fever (39 degrees C), 4 days after a colonoscopy. Further investigations eliminated carcinomatous mastitis and blood cultures were positive for group B beta-hemolytic streptococcus (Streptococcus agalactiae). Histological examination of a sigmoid polyp revealed a tubular adenocarcinoma.

Discussion: We report the first documented case of secondary dermal-hypodermal bacterial skin infection (cellulitis) due to group B beta-hemolytic streptococcus. The occurrence after colonoscopy examination, chronology of clinical features, bilaterality and positive blood cultures are arguments in favor of the secondary nature of the skin infection process.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adenocarcinoma / complications
  • Adenocarcinoma / surgery
  • Aged
  • Amoxicillin / administration & dosage
  • Amoxicillin / therapeutic use
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Infective Agents / administration & dosage
  • Anti-Infective Agents / therapeutic use
  • Breast Diseases / complications
  • Breast Diseases / drug therapy
  • Breast Diseases / etiology*
  • Cellulitis / complications
  • Cellulitis / drug therapy
  • Cellulitis / etiology*
  • Clavulanic Acid / administration & dosage
  • Clavulanic Acid / therapeutic use
  • Colonic Polyps / diagnosis
  • Colonic Polyps / surgery
  • Colonoscopy
  • Drug Therapy, Combination
  • Female
  • Humans
  • Metronidazole / administration & dosage
  • Metronidazole / therapeutic use
  • Rifampin / administration & dosage
  • Rifampin / therapeutic use
  • Sepsis / complications*
  • Sepsis / drug therapy
  • Sigmoid Neoplasms / complications
  • Sigmoid Neoplasms / diagnosis
  • Sigmoid Neoplasms / surgery
  • Streptococcal Infections / complications*
  • Streptococcal Infections / drug therapy
  • Streptococcus agalactiae*
  • Time Factors
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Metronidazole
  • Clavulanic Acid
  • Amoxicillin
  • Rifampin